Líder comprometido en ciberseguridad de productos sanitarios

Spacelabs es un líder comprometido en ciberseguridad de productos sanitarios. Analizamos continuamente nuestros productos en colaboración con clientes, agencias reguladoras y expertos externos para identificar y abordar posibles vulnerabilidades. Las siguientes advertencias se proporcionan para ayudar mejor a nuestros clientes a identificar cualquier posible vulnerabilidad del producto o del sistema. Las advertencias se publican en inglés.

• “Name:Wreck” Vulnerability Assessment and Potential Product Impact Statement
  Update: 19 August 2024
• CrowdStrike Vulnerability Assessment and Potential Product Impact Statement
  Update: 15 August 2024
• Mirth Connect RCE Vulnerability Assessment and Potential Product Impact Statement
  Last Update: 7 October 2023
• Artifex Ghostscript Vulnerability Assessment and Potential Product Impact Statement
  Last Update: 21 August 2023
• VMWare “Spring4Shell” Vulnerability Assessment and Potential Product Impact Statement
  Last Update: 8 July 2022
• Axeda “Access:7” Vulnerability Assessment and Potential Product Impact Statement
  Last update: 23 March 2022
• Log4Shell vulnerability assessment and potential product impact statement (CVE-2021-44228)
• BadAlloc Vulnerability Assessment and Potential Product Impact Statement (ICSA-21-119-04)
• SolarWinds Orion Code Compromise Threat Assessment and Potential Product Impact Statement (CISA Emergency Directive 21-01)
• AMNESIA:33 Vulnerability Assessment and Potential Product Impact Statement (ICSA-20-343-01)
• Ryuk Malware Threat Assessment and Potential Product Impact Statement (AA20-302A)
• CryptoAPI Product Cybersecurity Vulnerability Impact Assessment Report (CVE-2020-0601)
• DejaBlue vulnerability impact assessment report (CVE-2019-1181, CVE-2019-1182)
• Urgent-11 vulnerability in VxWorks IPNet service
• BlueKeep: RDP vulnerability in older Microsoft operating systems (CVE-2019-0708)
• Meltdown and Spectre vulnerabilities (CVE-2017-5754, CVE-2017-5753, CVE-2017-5715,)
• WannaCry malware vulnerability assessment and Microsoft patch compatibility statement (TA17-132A)